{"id":"https://openalex.org/W4393071413","doi":"https://doi.org/10.1158/1538-7445.am2024-871","title":"Abstract 871: Unveiling the potential of bispecific antibodies: A comprehensive analysis of efficiency, toxicity, and repurposing in cancer treatment","display_name":"Abstract 871: Unveiling the potential of bispecific antibodies: A comprehensive analysis of efficiency, toxicity, and repurposing in cancer treatment","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393071413","doi":"https://doi.org/10.1158/1538-7445.am2024-871"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-871","doi":"https://doi.org/10.1158/1538-7445.am2024-871","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-871","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100415584","display_name":"Binbin Wang","orcid":"https://orcid.org/0000-0003-2885-6428","observed_orcids":["https://orcid.org/0000-0003-2885-6428"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Binbin Wang","raw_affiliation_strings":["1NIH-NCI, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NIH-NCI, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030786757","display_name":"Sanna Madan","orcid":"https://orcid.org/0000-0001-8865-5789","observed_orcids":["https://orcid.org/0000-0001-8865-5789"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanna Madan","raw_affiliation_strings":["1NIH-NCI, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NIH-NCI, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000317216","display_name":"Alejandro A. Sch\u00e4ffer","orcid":"https://orcid.org/0000-0002-2147-8033","observed_orcids":["https://orcid.org/0000-0002-2147-8033"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alejandro Schaffer","raw_affiliation_strings":["1NIH-NCI, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NIH-NCI, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063492133","display_name":"Eytan Ruppin","orcid":"https://orcid.org/0000-0002-7862-3940","observed_orcids":["https://orcid.org/0000-0002-7862-3940"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eytan Ruppin","raw_affiliation_strings":["1NIH-NCI, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1NIH-NCI, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"871","last_page":"871"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.029999999329447746,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":1.0},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8130000233650208},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6610000133514404},{"id":"https://openalex.org/keywords/single-cell-transcriptomics","display_name":"single-cell transcriptomics","score":0.6639999747276306}],"concepts":[{"id":"https://openalex.org/C519536355","wikidata":"https://www.wikidata.org/wiki/Q21021151","display_name":"Repurposing","level":2,"score":0.6963801383972168},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.6895155310630798},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6291377544403076},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5723089575767517},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.539738118648529},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.48393136262893677},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43409931659698486},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.43060722947120667},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3627374768257141},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2303515076637268},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1437598466873169},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.0637761652469635},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-871","doi":"https://doi.org/10.1158/1538-7445.am2024-871","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-871","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409632140","https://openalex.org/W4412883843","https://openalex.org/W4416612115","https://openalex.org/W2410709360","https://openalex.org/W4399204785","https://openalex.org/W2409258749","https://openalex.org/W7172129126","https://openalex.org/W2225363868","https://openalex.org/W2073161107","https://openalex.org/W3195003274"],"abstract_inverted_index":{"Abstract":[0],"Bispecific":[1],"antibodies":[2,59,149],"have":[3],"emerged":[4],"as":[5],"promising":[6],"candidates":[7],"for":[8,14,208],"cancer":[9,26,127,155,199],"treatment,":[10],"prompting":[11],"the":[12,36,81,94,118,145,152,185,205],"necessity":[13],"a":[15,160],"comprehensive":[16,191],"understanding":[17],"of":[18,40,83,96,120,147,154,164,169,187,193,204],"their":[19],"potential":[20,119,146,186],"efficacy":[21,37,67,102],"and":[22,38,69,103,129,196],"toxicity":[23,39,71,104],"across":[24,46],"various":[25],"types.":[27],"Leveraging":[28],"single":[29],"cell":[30,42],"sequencing":[31],"data,":[32],"we":[33,50,99],"systematically":[34,124],"evaluated":[35],"all":[41],"surface":[43],"gene":[44,53,74,166],"pairs":[45,54,75,167],"multiple":[47],"cancers.":[48],"First,":[49],"found":[51],"that":[52,78],"involved":[55],"in":[56,76,86,198],"successful":[57,108],"bispecific":[58,89,133,148,172,188],"phase":[60,109],"I/II":[61,110],"clinical":[62,111],"trials":[63],"exhibited":[64],"significantly":[65],"higher":[66],"scores":[68,72,105,115],"lower":[70],"than":[73],"those":[77],"failed,":[79],"underscoring":[80],"utility":[82],"our":[84],"method":[85],"selecting":[87],"high-quality":[88],"pairs.":[90,135],"Second,":[91],"to":[92,116,150],"facilitate":[93],"identification":[95],"new":[97,132],"pairs,":[98],"established":[100],"baseline":[101],"based":[106],"on":[107],"trials,":[112],"employing":[113],"these":[114],"assess":[117],"novel":[121],"combinations.":[122],"We":[123],"identified":[125],"both":[126],"type-specific":[128],"pan-cancer":[130],"candidate":[131,165],"antibody":[134],"This":[136],"extensive":[137],"analysis":[138,192],"not":[139],"only":[140],"provides":[141],"valuable":[142],"insights":[143],"into":[144],"broaden":[151],"spectrum":[153],"treatments,":[156],"but":[157],"also":[158],"yields":[159],"highly":[161],"confident":[162],"list":[163],"capable":[168],"constructing":[170],"effective":[171],"antibodies.":[173],"Citation":[174],"Format:":[175],"Binbin":[176],"Wang,":[177],"Sanna":[178],"Madan,":[179],"Alejandro":[180],"Schaffer,":[181],"Eytan":[182],"Ruppin.":[183],"Unveiling":[184],"antibodies:":[189],"A":[190],"efficiency,":[194],"toxicity,":[195],"repurposing":[197],"treatment":[200],"[abstract].":[201],"In:":[202],"Proceedings":[203],"American":[206],"Association":[207],"Cancer":[209,227],"Research":[210],"Annual":[211],"Meeting":[212],"2024;":[213],"Part":[214],"1":[215],"(Regular":[216],"Abstracts);":[217],"2024":[218],"Apr":[219],"5-10;":[220],"San":[221],"Diego,":[222],"CA.":[223],"Philadelphia":[224],"(PA):":[225],"AACR;":[226],"Res":[228],"2024;84(6_Suppl):Abstract":[229],"nr":[230],"871.":[231]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2024-03-23T00:00:00"}